PURPOSE Pancreatic cancer surveillance in high-risk individuals may lead to detection of
pancreatic ductal adenocarcinoma (PDAC) at an earlier stage and with improved survival …

Objectives To evaluate the nature, diagnosis, treatment and prognosis of second primary
renal cell carcinoma (SPRCC). Materials and Methods We retrospectively collected data …

Background Previously, we characterized subtypes of pancreatic ductal adenocarcinoma
(PDAC) on computed-tomography (CT) scans, whereby conspicuous (high delta) PDAC …

The cancer survivor population is growing due to advances in detection and treatment. For
improved long-term patient management, it is critical to examine the clinical characteristics …

Background The incidence of a second de novo pancreatic ductal adenocarcinoma (PDAC)
among patients with prior cancer has been reported to be 6%., however, as survival …

Objective Second primary renal cell carcinoma (2nd RCC) refers to renal cell carcinoma
(RCC) diagnosed after another unrelated malignancy. This study aims to compare the …

Background With advances in early diagnosis and treatment, the number of cancer survivors
continues to grow, and more and more cancer survivors face the threat of second primary …

Methods Data on individuals diagnosed with primary cancers between 1993 and 2017 were
obtained from the Korea Central Cancer Registry. The standardized incidence ratios (SIRs) …

Objectives To investigate the characteristics, diagnosis, survival and prognosis of second
primary breast carcinoma (SPBC). Materials and methods Records of 123 patients with …

Purpose This study aimed to evaluate the clinicopathological features and oncological
outcomes of pancreatic cancer (PC) patients with prior malignancies (2nd primary PC) …